Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
10/2000
10/12/2000WO2000059503A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO2000059502A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO2000034287A3 Spirocyclic thienopyrans as potassium channel activators
10/12/2000CA2373717A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000CA2368686A1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase
10/12/2000CA2366944A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000CA2365578A1 Thienopyrimidine compounds and salts thereof and process for the preparation of the same
10/12/2000CA2361734A1 Pharmaceutically active compounds and methods of use thereof
10/11/2000EP1043326A1 Steroid receptor modulator compounds and methods
10/11/2000EP1043325A1 Steroid receptor modulator compounds and methods
10/11/2000EP1043315A1 Steroid receptor modulator compounds and methods
10/11/2000EP1042329A1 Novel farnesyl transferase inhibitors, preparation, pharmaceutical, compositions containing them and use for preparing medicines
10/11/2000EP1042322A1 Kv2.1 ANTAGONISTS
10/11/2000EP1042315A1 Cyclic imide-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents
10/11/2000EP1042291A1 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents
10/11/2000EP1041979A1 Esters of conjugated linoleic acid or conjugated linolenic acid and uses thereof
10/11/2000EP0749435B1 Interference suppression agent for use in immuno assaying
10/11/2000CN1269793A Pyrimidin-2-oxy-4-one and pyrimidin-2-oxy-40thione derivatives
10/10/2000US6130339 A 1-(3,4-ethylenedioxythien-2-yl)-4-aminobenzene
10/10/2000US6130229 Tricyclic compounds having activity as RAS-FPT inhibitors
10/10/2000US6130223 Thienopyrimidine with phosphodiesterase V inhibiting effect
10/05/2000WO2000058307A2 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands
10/05/2000WO2000058305A1 Novel compounds
10/05/2000WO2000058258A1 Novel carboxylic acid derivatives and process for producing the same
10/05/2000WO2000042026B1 Non-peptide glp-1 agonists
10/05/2000DE19914949A1 New tricyclic diketone derivatives which are useful as herbicides which have good crop plant tolerability and good effectiveness at low application rates
10/05/2000DE19914948A1 New tricyclic isoxazole derivatives which are useful as herbicides which have good crop plant tolerability and good effectiveness at relatively low application rates
10/05/2000CA2365401A1 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands
10/05/2000CA2361366A1 Novel compounds
10/04/2000EP1041071A1 Methods for the preparation of coumarine derivatives
10/04/2000EP1041066A1 Steroid receptor modulator compounds and methods
10/04/2000EP1040098A1 Integrin receptor antagonists
10/04/2000EP1040097A1 Potassium channel openers
10/04/2000EP1039917A1 Pharmaceutical composition comprising ticlopidine and ginkgo biloba extract
10/04/2000CN1268949A Fused thiophene compounds and medical use thereof
10/04/2000CN1268942A Sulfonamide compounds and medicinal use thereof
10/04/2000CN1057083C Tricyclic 1-aminoethylpyrrol derivative
10/03/2000US6127374 An enzyme inhibitor for treating cancer, restenosis, atherosclerosis, endometriosis and psoriasis
10/03/2000US6127368 Anellated β-carbolines
09/2000
09/28/2000WO2000056739A1 Thienopyrimidine compounds, their production and use
09/28/2000WO2000056738A1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
09/28/2000CA2367866A1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
09/27/2000EP1037633A1 Antiviral compounds
09/27/2000CN1268138A Compounds
09/27/2000CN1056849C Fungistatin derivate and its preparing method and its application in pharmacy
09/27/2000CN1056832C Fused dihydropyridine derivate, its producing process, and its pharmaceutical composition
09/21/2000WO2000055358A1 4-(4-hydroxystyryl)pyridine-containing substrates for an analyte dependent enzyme activation system
09/21/2000WO2000055158A1 Tricyclic benzoylpyrazole derivatives used as a herbicide
09/21/2000WO2000055139A2 Heterocyclic urea and related compounds useful as anti-inflammatory agents
09/21/2000WO2000018407A9 Methods for preventing/treating damage to sensory hair cells and cochlear neurons
09/21/2000CA2368190A1 4-(4-hydroxystyryl)pyridine-containing substrates for an analyte dependent enzyme activation system
09/21/2000CA2367672A1 Tricyclic benzoylpyrazole derivatives used as a herbicide
09/20/2000EP1036078A1 Thienopyrimidines
09/20/2000EP1036076A1 Novel compounds
09/20/2000EP1036065A1 Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors
09/20/2000EP1035850A1 Inhibitors of farnesyl-protein transferase
09/20/2000CN1267303A 3-substd. 3,4,5,7-tetrahydro-pyrrolo [3',4' : 4,5] thieno [2,3-d] pyrimidine derivs, their preparation and use as 5HT antagonists
09/19/2000US6121259 Olanzapine-N-oxide compositions and methods
09/14/2000WO2000053610A2 4-OXO-4,7-DIHYDRO-THIENO[2,3-b]PYRIDINE-5-CARBOXAMIDES AS ANTIVIRAL AGENTS
09/14/2000WO2000053573A1 Medicinal compositions with [2.2.1] and [3.1.1] bicycloskeleton antagonistic to both of pgd2/txa2 receptors
09/14/2000WO1999063999A8 H1-histamine receptor antagonists
09/14/2000CA2366609A1 4-oxo-4,7-dihydro-thieno¬2,3-b|pyridine-5-carboxamides as antiviral agents
09/13/2000CN1056374C Tricyclic diazepine vasopression antagonists
09/12/2000US6118010 Catalytic reduction of the 1-alkoxycarbonyl-3-oxo-3-phenylpropyl derivative
09/06/2000CN1265661A N-acylamino acid amide compounds and intermediates for preparation thereof
09/05/2000US6114526 Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
09/05/2000US6114374 2-and 2,5-substituted phenylketoenols
09/05/2000US6114338 Heterocyclic compounds
09/05/2000CA2019301C Process for the preparation of phenylacetic derivatives of thienopyridines and of the intermediate .alpha.-bromo-phenylacetic acids
08/2000
08/31/2000WO2000012074A3 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
08/30/2000EP1031563A1 Sulfonyl derivatives
08/30/2000EP1030840A1 Cyclic amine derivatives and their use as drugs
08/30/2000EP1030662A2 Treatment of t-helper cell type 2 mediated immune diseases with retinoid antagonists
08/29/2000US6110964 For treating arthritis, inflammatory bowel disease, crohn's disease, emphysema, acute respiratory distress syndrome, asthma chronic obstructive pulmonary disease, alzheimer's disease, organ transplant toxicity, cachexia, cancer
08/29/2000US6110920 Treatment of cardiovascular disorders and impotency
08/29/2000US6110914 Spiroazabicyclic heterocyclic compounds
08/29/2000US6110910 Antiinflammatory agents, antiarthritic agents, antirheumatic agents, anticarcinogenic agents
08/29/2000US6110872 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides
08/29/2000US6110400 Fulgimide compound and use thereof and composition containing said compound
08/24/2000WO2000037470A8 Antihistaminic spiro compounds
08/23/2000EP1028964A1 Thienopyrimidine and thienopyridine derivatives useful as anticancer agents
08/23/2000EP0861228B1 Lipopolyamines as transfection agents and pharmaceutical uses thereof
08/23/2000EP0698023B1 Fibrinogen receptor antagonists
08/23/2000CN1264383A Salts of optically active sulfoxide derivative
08/23/2000CN1264382A Novel compounds
08/22/2000US6107494 Substituted 5-aryl-benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
08/22/2000US6107304 Anemia
08/22/2000US6107024 Using 1,2-dioxetane derivative substrate in enzyme-linked assay where enzyme is linked to antigen, antibody, hapten or nucleic acid; forms aryloxide intermediate when triggered, then releases energy to form light and two carbonyl compounds
08/22/2000CA2143246C Imidazodiazepines
08/16/2000EP1027052A1 Novel combination
08/16/2000CN1263095A New tricycloacylamide compound, its preparation method and medicinal composition containing them
08/16/2000CN1055471C Substituted imidazolidines, their preparing process, and intermediates, their pharmaceutical compositions and there use
08/15/2000US6103903 Anxiolytic agents, anticonvulsants, cognition activators
08/15/2000US6103736 Showing an inhibitory action on gastric acid secretion and a protective action of gastric mucosa; 2-(hetero)aryl-3-aminoimidazo-(2,1-a)isoquinolines; antiulcer agents;
08/15/2000US6103729 Cathecol derivatives and a method for the preparation thereof and a pharmaceutical composition containing the same
08/15/2000US6103721 Heteroaryl-substituted pyridazino quinoline compounds
08/10/2000WO2000046184A1 N2-phenylamidine derivatives
08/10/2000WO2000027822A3 Tricyclic pyrazole derivatives
08/10/2000WO2000008026A3 Fungicidal fused bicyclic heterocycles
08/10/2000WO1999063936A9 Novel therapeutic agents that modulate endothelin receptors
1 ... 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 ... 214